Suppr超能文献

全血用于失血:损伤控制中的止血复苏。

Whole blood for blood loss: hemostatic resuscitation in damage control.

机构信息

Hospital Vicente Corral Moscoso, Division of Trauma and Acute Care Surgery, Cuenca, Ecuador.

Universidad del Azuay, Escuela de Medicina. Cuenca, Ecuador.

出版信息

Colomb Med (Cali). 2020 Dec 30;51(4):e4044511. doi: 10.25100/cm.v51i4.4511.

Abstract

Hemorrhagic shock and its complications are a major cause of death among trauma patients. The management of hemorrhagic shock using a damage control resuscitation strategy has been shown to decrease mortality and improve patient outcomes. One of the components of damage control resuscitation is hemostatic resuscitation, which involves the replacement of lost blood volume with components such as packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets in a 1:1:1:1 ratio. However, this is a strategy that is not applicable in many parts of Latin America and other low-and-middle-income countries throughout the world, where there is a lack of well-equipped blood banks and an insufficient availability of blood products. To overcome these barriers, we propose the use of cold fresh whole blood for hemostatic resuscitation in exsanguinating patients. Over 6 years of experience in Ecuador has shown that resuscitation with cold fresh whole blood has similar outcomes and a similar safety profile compared to resuscitation with hemocomponents. Whole blood confers many advantages over component therapy including, but not limited to the transfusion of blood with a physiologic ratio of components, ease of transport and transfusion, less volume of anticoagulants and additives transfused to the patient, and exposure to fewer donors. Whole blood is a tool with reemerging potential that can be implemented in civilian trauma centers with optimal results and less technical demand.

摘要

失血性休克及其并发症是创伤患者死亡的主要原因。采用损伤控制性复苏策略治疗失血性休克已被证明可降低死亡率并改善患者预后。损伤控制性复苏的一个组成部分是止血复苏,其中包括用红细胞悬液、新鲜冰冻血浆、冷沉淀和血小板以 1:1:1:1 的比例替代丢失的血容量。然而,在拉丁美洲和世界其他中低收入国家的许多地区,这种策略并不适用,因为这些地区缺乏设备齐全的血库,血液制品的供应也不足。为了克服这些障碍,我们建议在出血性休克患者中使用冷新鲜全血进行止血复苏。厄瓜多尔 6 年多的经验表明,用冷新鲜全血复苏与用血液成分复苏的结果相似,安全性也相似。全血相对于成分治疗具有许多优势,包括但不限于输注具有生理比例的血液成分、易于运输和输注、输注给患者的抗凝剂和添加剂的量更少,以及与更少的供体接触。全血是一种重新出现潜力的工具,可以在民用创伤中心实施,效果最佳,技术需求较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e76/7968429/2fb7d870b746/1657-9534-cm-51-04-e4044511-gf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验